Literature DB >> 26139236

Long-term renal outcomes in a cohort of 1814 Chinese patients with biopsy-proven lupus nephritis.

J Yang1, D Liang1, H Zhang1, Z Liu1, W Le1, M Zhou1, W Hu1, C Zeng1, Z Liu1.   

Abstract

In the present study, we observed the renal outcomes in a cohort of 1814 Chinese patients with biopsy-proven lupus nephritis (LN) and evaluated the risk factors associated with poor renal prognosis. The 5 -, 10 -, 15 - and 20-year renal survival rates were 93.1%, 87.9%, 81.0% and 68.3%, respectively. Gender, LN duration, mean arterial pressure (MAP), proteinuria, serum creatinine, haemoglobin and pathological classification at the time of biopsy were independent risk factors for end-stage renal disease (ESRD). The long-term renal outcomes of patients with class II LN were unfavorable as opposed to those with class V. Additionally, the time-average proteinuria (TA-Pro) and the time-average mean arterial pressure (TA-MAP) during the follow-up were important risk factors for ESRD, with better predictive values than the baseline proteinuria and MAP. The results underscore the need for proteinuria and blood pressure control during follow-up in patients with LN; proteinuria levels should be controlled at least to < 1.0 g/24 h, and optimally to < 0.5 g/24 h; MAP should not exceed 96.5 mmHg. More attention should be paid to class II LN and emphasis should be placed on recurrence prevention of class II LN.
© The Author(s) 2015.

Entities:  

Keywords:  Lupus nephritis; renal outcome; risk factor; time-average mean arterial pressure; time-average proteinuria

Mesh:

Substances:

Year:  2015        PMID: 26139236     DOI: 10.1177/0961203315593166

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  13 in total

1.  Combined immunosuppressive treatment (CIST) in lupus nephritis: a multicenter, randomized controlled study.

Authors:  Yuan An; Yunshan Zhou; Liqi Bi; Bo Liu; Hong Wang; Jin Lin; Danyi Xu; Mei Wang; Jing Zhang; Yongfu Wang; Yan An; Ping Zhu; Ronghua Xie; Zhiyi Zhang; Yifang Mei; Xiangyuan Liu; Xiaoli Deng; Zhongqiang Yao; Zhuoli Zhang; Yu Wang; Weiguo Xiao; Hui Shen; Xiuyan Yang; Hanshi Xu; Feng Yu; Guochun Wang; Xin Lu; Yang Li; Yingnan Li; Xiaoxia Zuo; Yisha Li; Yi Liu; Yi Zhao; Jianping Guo; Lingyun Sun; Minghui Zhao; Zhanguo Li
Journal:  Clin Rheumatol       Date:  2018-11-28       Impact factor: 2.980

2.  Autologous Hematopoietic Stem Cell Transplantation for Refractory Lupus Nephritis.

Authors:  Xianghua Huang; Wencui Chen; Guisheng Ren; Liang Zhao; Jinzhou Guo; Dehua Gong; Caihong Zeng; Weixin Hu; Zhihong Liu
Journal:  Clin J Am Soc Nephrol       Date:  2019-04-12       Impact factor: 8.237

3.  The relationship between neutrophil-lymphocyte ratio and early renal fibrosis and renal prognosis in patients with lupus nephritis.

Authors:  Guming Zou; Hongmei Gao
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

4.  Long-term renal outcomes of mesangial proliferative lupus nephritis in Chinese patients.

Authors:  Shaofan Wang; Duqun Chen; Ke Zuo; Feng Xu; Weixin Hu
Journal:  Clin Rheumatol       Date:  2021-09-22       Impact factor: 2.980

5.  Glomerular Exostosin as a Subtype and Activity Marker of Class 5 Lupus Nephritis.

Authors:  Chengyu Wang; Yang Liu; Mingchao Zhang; Fan Yang; Feng Xu; Shaolin Shi; Caihong Zeng; Xin Chen; Yiqi Miao; Zhengzhao Liu; Weixin Hu
Journal:  Clin J Am Soc Nephrol       Date:  2022-05-18       Impact factor: 10.614

6.  Long-term Outcome of Lupus Nephritis Class II in Argentine Patients: An Open Retrospective Analysis.

Authors:  Maria Victoria Collado; Enrique Dorado; Silvia Rausch; Graciela Gomez; Marina Khoury; Federico Zazzetti; María Gargiulo; Lorena Suarez; Rafael Chaparro; Sergio Paira; Laura Galvan; Vicente Juarez; Cecilia Pisoni; Mercedes Garcia; Liliana Martinez; Analia Alvarez; Clarisa Alvarez; Juan Barreira; Judith Sarano
Journal:  J Clin Rheumatol       Date:  2016-09       Impact factor: 3.517

7.  Causes and predictors of mortality in biopsy-proven lupus nephritis: the Sarawak experience.

Authors:  Cheng Lay Teh; Vui Eng Phui; Guo Ruey Ling; Lui-Sian Ngu; Sharifah Aishah Wan; Clare Hui-Hong Tan
Journal:  Clin Kidney J       Date:  2017-07-17

8.  Repeated administration of alpha-galactosylceramide ameliorates experimental lupus nephritis in mice.

Authors:  Takahiro Uchida; Hiroyuki Nakashima; Akira Yamagata; Seigo Ito; Takuya Ishikiriyama; Masahiro Nakashima; Shuhji Seki; Hiroo Kumagai; Naoki Oshima
Journal:  Sci Rep       Date:  2018-05-29       Impact factor: 4.379

9.  Treatment and clinicopathological characteristics of lupus nephritis with anti-neutrophil cytoplasmic antibody positivity: a case-control study.

Authors:  Cui Li; Min-Lin Zhou; Dan-Dan Liang; Jing-Jing Wang; Jing Yang; Cai-Hong Zeng; Zhi-Hong Liu; Hai-Tao Zhang
Journal:  BMJ Open       Date:  2017-07-28       Impact factor: 2.692

10.  Outcomes of membranous and proliferative lupus nephritis - analysis of a single-centre cohort with more than 30 years of follow-up.

Authors:  Filipa Farinha; Ruth J Pepper; Daniel G Oliveira; Thomas McDonnell; David A Isenberg; Anisur Rahman
Journal:  Rheumatology (Oxford)       Date:  2020-11-01       Impact factor: 7.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.